Both in Pharmaceuticals
CNS Pharmaceuticals vs Aprea Therapeutics
Over the past year CNSP returned −41.4% and APRE returned −67.1%; their daily moves had a correlation of 0.05.
CNSP −41.4% APRE −67.1%Growth of $1, one year, split-adjusted
| Metric | CNSP | APRE |
|---|---|---|
| Price | $4.45 | $0.4770 |
| Market cap | $6.5M | $6.0M |
| Today | −6.71% | −3.36% |
| 1 month | −15.1% | −34.1% |
| 6 months | +92.5% | −41.7% |
| Year to date | −15.2% | −44.1% |
| 1 year | — | −67.1% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 1,158.3× |
| Net cash | $20.0M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 69.3% | 95.7% |
| Short % of float | 0.1% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).